Skip to main content
. 2024 Jun 28;15:1418177. doi: 10.3389/fendo.2024.1418177

Table 1.

Patients characteristics at initial visit.

All n = 126 Low group
n = 32
Middle group
n = 67
High group
n = 27
P-value
Age (years) 45.9 ± 13.9 44.8 ± 13.4 47.3 ± 15.4 43.8 ± 10.2 0.483
Men, n (%) 41 (32.5) 11 (34.4) 18 (26.9) 12 (44.4) 0.250
Height (cm) 161.8 ± 8.4 161.8 ± 8.2 161.1 ± 8.3 163.7 ± 8.8 0.412
Body weight (kg) 99.2 ± 23.2 98.9 ± 22.5 97.3 ± 23.7 104.0 ± 22.8 0.457
Body mass index (kg/m2) 37.7 ± 7.6 37.5 ± 6.4 37.4 ± 8.0 38.8 ± 7.7 0.708
Medical history
 Hypertension, n (%) 59 (46.8) 15 (46.9) 32 (47.8) 12 (44.4) 0.958
 Dyslipidemia, n (%) 35 (27.8) 9 (28.1) 19 (28.4) 7 (25.9) 0.971
 Diabetes mellitus, n (%) 29 (23) 12 (37.5) 11 (16.4) 6 (22.2) 0.066
Medication
 A ntihypertensives, n (%) 46 (36.8) 13 (40.6) 23 (34.8) 10 (37.0) 0.856
 Hypolipidemic agent, n (%) 31 (25.0) 9 (28.1) 16 (26.4) 6 (22.2) 0.868
 Insulin, n (%) 2 (1.6) 2 (6.3) 0 (0.0) 0 (0.0) 0.054
 Oral hypoglycemic agent,
 n (%)
26 (20.8) 12 (37.5)* 8 (12.1) 6 (22.2) 0.014
Lifestyle
 Current smoker, n (%) 9 (7.6) 5 (16.7) 2 (3.2) 2 (7.4) 0.073
 Alcoholic drinks, n (%) 38 (31.9) 10 (33.3) 21 (32.8) 7 (28.0) 0.892
 Exercise habits, n (%) 42 (36.8) 12 (37.5) 22 (33.8) 8 (29.6) 0.817

Data are expressed as mean ± standard deviation or median (interquartile range).

*P < 0.05 vs. Middle group.